Alopecia – Global Clinical Trials Review, 2022

The alopecia clinical trials report provides a comprehensive overview of the alopecia clinical trials landscape. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on number of ongoing trials).

What are the market dynamics in the alopecia clinical trial market?

Alopecia clinical trials report consists of more than 600 trials. Trials conducted by companies are in Phase IV, Phase III, Phase II, Phase I and Phase 0. Similarly, the trials with different status compile of completed, ongoing, planned, terminated and withdrawn.

Which are the key regions in the alopecia clinical trial market?

The key regions in the alopecia clinical trials market are Asia-Pacific, Middle East & Africa, Europe, North America, and Central & South America.

Alopecia clinical trials market in Asia- Pacific

India, China, Japan, South Korea, and Thailand are the key countries in the alopecia clinical trials market in Asia – Pacific. India has the highest number of clinical trials followed by China, Japan, South Korea and Thailand.

Alopecia clinical trials market in Europe

Germany, France, Russia, Belgium, and the United Kingdom are the key countries in Europe in the alopecia clinical trials market. Germany has the highest number of clinical trials among them, followed by France, Russia, Belgium and the UK.

Alopecia clinical trials market in North America

The US, Canada, and Mexico are the key countries in the alopecia clinical trials market in North America. The US has the highest number of clinical trials in the region, followed by Canada and Mexico.

Alopecia clinical trials market in Middle East & Africa

Iran, Egypt, Israel, Kuwait, and Lebanon are the key countries in Middle East & Africa in the alopecia clinical trials market. Among them Iran has the highest number of clinical trials of alopecia, followed by Egypt, Israel, and Kuwait.

Alopecia clinical trials market in Central & South America

Brazil, Argentina, Chile, Colombia, and Peru are the key countries in the alopecia clinical trials market in Central & South America. Brazil has the highest number of clinical trials, followed by Argentina, Chile, Colombia, and Peru.

Alopecia clinical trials market in G7 countries

The G7 countries include the US, the UK, Germany, France, Italy, Canada, and Japan. Among them the US has the highest number of clinical trials of alopecia.

Alopecia clinical trials market in E7 countries

China, India, Russia, Brazil, Mexico, Turkey, and Indonesia are the E7 countries. Among them India has the highest number of clinical trials of alopecia.

Alopecia clinical trials market, by region

For more regional insights, download a free sample

Who are the key sponsors in the alopecia clinical trial market?

Pfizer Inc, Concert Pharmaceuticals Inc, Johnson & Johnson, AbbVie Inc, Aclaris Therapeutics Inc, Kintor Pharmaceutical Ltd, Applied Biology Inc, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, and Almirall SA are the key sponsors in the alopecia clinical trial market.

Alopecia clinical trials market, by key sponsors

To know more about key sponsors, download a free sample

Market report scope

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status
• The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
• The report provides all the unaccomplished trials (terminated, suspended and withdrawn) with reason for failure
• The report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level